Delivery Order SPE2DB20D3103-SPE2DB25FL6E6
Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,487.22 firm-fixed-price delivery order is for the supply of HYDRALAZINE 20 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 14, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of Hydralazine 20 mg/ml vials to the Defense Logistics Agency (DLA). The contract, valued at $1,050.97, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydralazine 20 mg/ml vial, a medication used for the treatment of hypertension. The award, valued at $2,326.77, is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The contract has no set-aside designation, indicating open competition....
- This federal contract award with ID SPE2DB20D3505|SPE2DB25FT3A9 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.32 firm fixed-price delivery order is for the supply of 4,566,181,522 units of the pharmaceutical product Hydralazine 25 mg tablet. The contract has an ultimate completion date of October 23, 2024. This award is not designated as a set-aside contract. AmerisourceBergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,050.40, is for the supply of Hydralazine 20 mg/ml vial, a medication used to treat high blood pressure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydralazine 20 mg/ml vials. The contract has a ceiling value of $1,327.85 and a performance period through June 27, 2025. The contract is not set aside and allows for the delivery of both brand-name and generic pharmaceutical products to support military and government healthcare needs. AmerisourceBergen Drug Corp...
- This contract award is for the delivery of hydralazine 20 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $45,324.24 and is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award, valued at $5,033.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydralazine 20 mg/mL vials, a medication used to treat high blood pressure. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Hydralazine 20 mg/ml vial, a medication used to treat high blood pressure. The contract has a firm fixed price of $3,987.58 and a period of performance ending on July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order (SPE2DB20D3103|SPE2DB24FP2K1) from the Defense Logistics Agency (DLA) for hydromorphone 2 mg/ml vials, with a ceiling value of $1,435.38 and an ultimate completion date of June 21, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...